Advanced Medical Isotope (RDGL) Stock Price, News & Analysis

Company Overview

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Key Stats

• Today's Range: $0.07 to $0.09
• 50-Day Range: $0.09 to $0.14
• 52-Week Range: $0.04 to $0.18
• Volume: 3.46 million shs
• Average Volume: 1.19 million shs
• Market Capitalization: $36.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RDGL Stock Analysis - Frequently Asked Questions

How have RDGL shares performed this year?

Advanced Medical Isotope's stock was trading at $0.1149 at the start of the year. Since then, RDGL stock has decreased by 30.5% and is now trading at $0.0799.

How do I buy shares of Advanced Medical Isotope?

Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Advanced Medical Isotope own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Medical Isotope investors own include MannKind (MNKD), Agenus (AGEN), APA (APA), Aphria (APHA), Bionano Genomics (BNGO), Churchill Capital Corp IV (CCIV) and Canopy Growth (CGC).

Company Calendar

• Today: 8/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Finance
• Industry: FIN - SBIC&COMMRL
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:RDGL
• CIK: 1449349
• Web: www.radiogel.com
• Phone: (509) 736-4000
• Fax: 509-736-4007
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.91 million
• Net Margins: -6,401.92%
• Pretax Margin: -6,401.92%
• Return on Equity: N/A
• Return on Assets: -139.36%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 28.78
• Quick Ratio: 28.13

Sales & Book Value

• Annual Sales: $30 thousand
• Price / Sales: 1,187.89
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.02) per share
• Price / Book: -3.92

Miscellaneous

• Outstanding Shares: 454,550,000
• Free Float: 370,456,000
• Market Cap: $35.64 million
• Optionable: Not Optionable
• Beta: 1.09